[1]MOLKENTIN J D, BLACK B L, MARTIN J F, et al. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins[J]. Cell, 1995, 83(7): 1125-1136. [2]WANG D Z, VALDEZ M R, MCANALLY J, et al. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development[J]. Development, 2001, 128(22): 4623-4633. [3]MCKINSEY T A, ZHANG C L, OLSON E N. MEF2: a calcium-dependent regulator of cell division, differentiation and death[J]. Trends Biochem Sci, 2002, 27(1): 40-47. [4]GENIKHOVICH G, TECHNAU U. Complex functions of Mef2 splice variants in the differentiation of endoderm and of a neuronal cell type in a sea anemone[J]. Development, 2011, 138(22): 4911-4919. [5]张文炜, 徐列明. 转录因子MEF2对多种信号通路的调节及生物学作用[J]. 中国生物化学与分子生物学报, 2004, 20(4):423-427. [6]ZHOU Y, LIU Y, JIANG X, et al. Polymorphism of chicken myocyte-specific enhancer-binding factor 2A gene and its association with chicken carcass traits[J]. Mol Biol Rep, 2010, 37: 587-594. [7]周艳, 刘益平, 蒋小松, 等. 优质鸡MEF2A 基因的SNPs检测及其与屠体性状的相关研究[J]. 畜牧兽医学报, 2009, 40(8): 1164-1170. [8]CHEN F Y, CHEN H, LAN X Y, et al. MEF2A gene polymorphisms are associated with growth traits in Chinese indigenous cattle breeds [J] . Anim Vet Ad, 2010, 9(4): 814-819. [9]MILLIGAN J N, JOLLY E R. Identification and characterization of a Mef2 transcriptional activator in schistosome parasites[J]. PLoS Negl Trop Dis, 2012, 6(1): e1443. [10]WANG L J, FAN C, TOPOL S E, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease[J]. Science, 2003, 302(5650): 1578-1581. [11]MAIOLINO G, COLONNA S, ZANCHETTA M, et al. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family[J]. Eur J Cardiovasc Prev Rehabil, 2011, 18(4): 557-560. [12]戴大鹏, 何青, 周晓阳, 等. MEF2A基因CAG三联核苷酸重复序列与冠状动脉粥样硬化性心脏病的相关研究[J]. 中华老年心脑血管病杂志, 2006, 8: 671-674. [13]戴大鹏, 郑君德, 周晓阳, 等. MEF2A第11号外显子CAG三联核苷酸重复序列的改变与其转录激活活性的相关性[J]. 医学研究杂志, 2009, 38(4): 22-25. [14]ROZANSKA M, SOBCZAK K, JASINSKA A, et al. CAG and CTG repeat polymorphism in exons of human genes shows distinct features at the expandable loci[J]. Hum Mutat, 2007, 28(5): 451-458. [15]田然. 冠心病相关基因肌细胞增强因子2A突变型真核表达载体的构建及核定位研究[D].北京: 北京协和医学院, 2009. [16]周晓阳, 何青, 戴大鹤, 等. MEF2A基因第11号外显子突变的检测及其基因结构分析[J]. 中国分子心脏病学杂志, 2006, 6(4): 208-211. [17]HSU L A, CHANG C J, TENG M S, et al. CAG repeat polymorphism of the MEF2A gene is not associated with the risk of coronary artery disease among taiwanese[J]. Clin Appl Thromb/Hem, 2010, 16(3): 301-305. [18]SAMAR E, OLYAN A B, PAUL M, et al. A study of the role of the myocyte-specific enhancer factor-2A gene in coronary artery disease[J]. Atherosclerosis, 2010, 209: 152-154. [19]GUELLA I, RIMOLDI V, ASSELTA R, et al. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease[J]. Circ Cardiovasc Genet, 2009, 2(2): 165-172. [20]DAI D P, ZHOU X Y, XIAO Y, et al. Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population[J]. Eur J Clin Invest, 2010, 40(8): 669-677. [21]KAJIMOTO K, SHIOJI K, TAGO N, et al. Assessment of MEF2A mutations in myocardial infarction in Japanese patients[J]. Circ J, 2005, 69(10): 1192-1195. [22]GULEC S, RUCHAN A A, AKAR N. MEF2A sequence variants in turkish population[J]. Clin Appl Throm/Hem, 2008, 14(4): 465-467. |